Free Trial

AbCellera Biologics (ABCL) SEC Filings & 10K Form

AbCellera Biologics logo
$5.80 +0.18 (+3.11%)
As of 12:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent AbCellera Biologics SEC Filings

DateFilerForm TypeView
09/10/2025
11:23 AM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2025
2:13 PM
AbCellera Biologics (Issuer)
Hayden Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
4:30 PM
AbCellera Biologics (Issuer)
Lo Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
4:32 PM
AbCellera Biologics (Issuer)
Montalbano John S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
12:20 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2025
12:46 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
4:15 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
1:33 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
5:42 PM
AbCellera Biologics (Issuer)
Thermopylae Holdings Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:11 PM
AbCellera Biologics (Issuer)
Montalbano John S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
2:32 PM
AbCellera Biologics (Issuer)
Montalbano John S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:36 PM
AbCellera Biologics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:24 PM
AbCellera Biologics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
3:11 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
10:56 AM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
2:44 PM
AbCellera Biologics (Issuer)
Stimart Tryn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
2:36 PM
AbCellera Biologics (Issuer)
Hansen Carl L. G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
2:37 PM
AbCellera Biologics (Issuer)
Booth Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
2:40 PM
AbCellera Biologics (Issuer)
Lecault Veronique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:47 PM
AbCellera Biologics (Issuer)
Thermopylae Holdings Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
4:38 PM
AbCellera Biologics (Issuer)
Hansen Carl L. G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ABCL) was last updated on 10/15/2025 by MarketBeat.com Staff
From Our Partners